Downloads
Revenue

Description

Dear Colleagues,
Summit 2022 is the 9th joint project of EHOG and MD Anderson Cancer Center Leukemia Department that will take place on May, 7-8 in İstanbul.
We are extremely happy to be able to organize this meeting in person after two years due to the pandemic.
As every year, distinguished MD Anderson Cancer CenterLeukemia Department physicians along with the other distinguished speakers from Europe will present their latest research findings and perspectives on the hematologic diseases at this two-day meeting.
The concept of the meeting is based on interactive presentations where the audience will be able to ask online questions to the speakers.
Looking forward to welcoming you to beautiful Istanbul.
On behalf of the Organizing Committee,
Prof. Birol Güvenç, MD
Hide Show More...

Screenshots

Summit 2022 FAQ

  • Is Summit 2022 free?

    Yes, Summit 2022 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Summit 2022 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Summit 2022 cost?

    Summit 2022 is free.

  • What is Summit 2022 revenue?

    To get estimated revenue of Summit 2022 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Belarus yet.
Ratings History

Summit 2022 Reviews

No Reviews in Belarus
App doesn't have any reviews in Belarus yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Summit 2022 Installs

Last 30 days

Summit 2022 Revenue

Last 30 days

Summit 2022 Revenue and Downloads

Gain valuable insights into Summit 2022 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English
Recent release
1.1 (2 years ago )
Released on
Apr 22, 2022 (2 years ago )
Last Updated
1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.